EWPI (Emerging World Pharma) Total Receivables: $0.00 Mil (As of . 20)


What is Emerging World Pharma Total Receivables?

Emerging World Pharma EWPI -98.00% Total Receivables is $0.00 Mil as of . 20.

Emerging World Pharma's Total Receivables for the quarter that ended in . 20 was $0.00 Mil.

Emerging World Pharma Total Receivables Related Terms

Emerging World Pharma Total Receivables Historical Data

* Premium members only.

The historical data trend for Emerging World Pharma's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emerging World Pharma Total Receivables Chart

Emerging World Pharma Annual Data
Trend
Total Receivables

Emerging World Pharma Quarterly Data
Total Receivables

Emerging World Pharma Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of $0.00 Mil mean?
Emerging World Pharma (EWPI) has a Total Receivables of $0.00 Mil as of . 20. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Emerging World Pharma and its competitors.
Is Emerging World Pharma's Total Receivables too high?
Emerging World Pharma's current Total Receivables is $0.00 Mil.
How does Emerging World Pharma's Total Receivables compare to ENZB and AOXG?
Emerging World Pharma's Total Receivables of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Emerging World Pharma and its competitors. Emerging World Pharma's current Total Receivables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emerging World Pharma stock overvalued right now?
Emerging World Pharma (EWPI) has a current Total Receivables of $0.00 Mil. The current Total Receivables is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Emerging World Pharma (EWPI), the current Total Receivables is $0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Emerging World Pharma Business Description

Address Block 11A, Pastoral Road, Sunyani, GHA, 20109
Emerging World Pharma Inc is an investor in generic based pharmaceutical companies manufacturing within developing nations.